ITGA8: A Potential Drug Target for Various Diseases (G8516)

Target Name: ITGA8

NCBI ID: G8516

ITGA8

ITGA8: A Potential Drug Target for Various Diseases

ITGA8 (Immunoglobulin G8) is a single-chain antibody that is expressed in various tissues and cells in the human body. ITGA8 has been identified as a potential drug target and has been shown to play a role in a variety of biological processes. In this article, we will discuss ITGA8 as a drug target and its potential applications in the treatment of various diseases.

Disease-RelatedITGA8 Expression

ITGA8 has been shown to be involved in a variety of diseases and disorders. One of the most well-studied functions of ITGA8 is its role in autoimmune diseases. ITGA8 has been shown to contribute to the development and progression of conditions such as rheumatoid arthritis, lupus, and multiple sclerosis.

In addition to its role in autoimmune diseases, ITGA8 has also been shown to be involved in other diseases such as cancer, neurodegenerative diseases, and infections. For example, studies have shown that ITGA8 is expressed in the brains of individuals with Alzheimer's disease and that its levels are decreased in individuals with Parkinson's disease. ITGA8 has also been shown to be involved in the development of cancer, with higher levels of ITGA8 being associated with a greater risk of cancer progression.

Targeting ITGA8

ITGA8 has been identified as a potential drug target due to its unique structure and the various functions it is involved in. One approach to targeting ITGA8 is to use antibodies that are designed to specifically bind to ITGA8 and prevent it from interacting with its receptors. These antibodies have been shown to be effective in treating a variety of diseases and disorders, including autoimmune diseases, cancer, and neurodegenerative diseases.

Another approach to targeting ITGA8 is to use small molecules that can inhibit its function. For example, researchers have shown that inhibitors of ITGA8 can be effective in treating neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. These inhibitors work by blocking ITGA8 from interacting with its receptors and preventing it from contributing to the development and progression of these diseases.

Potential Applications

ITGA8 has the potential to be a drug target for a variety of diseases and disorders. Its unique structure and various functions make it an attractive target for researchers and doctors. With further research, ITGA8 has the potential to be used to treat a wide range of diseases and disorders, including autoimmune diseases, cancer, neurodegenerative diseases, and infections.

Conclusion

In conclusion, ITGA8 is a protein that is expressed in various tissues and cells in the human body. It has been shown to play a role in a variety of biological processes and has the potential to be a drug target for a variety of diseases and disorders. Further research is needed to fully understand the role of ITGA8 and its potential applications in the treatment of various diseases.

Protein Name: Integrin Subunit Alpha 8

Functions: Integrin alpha-8/beta-1 functions in the genesis of kidney and probably of other organs by regulating the recruitment of mesenchymal cells into epithelial structures. It recognizes the sequence R-G-D in a wide array of ligands including TNC, FN1, SPP1 TGFB1, TGFB3 and VTN. NPNT is probably its functional ligand in kidney genesis. Neuronal receptor for TNC it mediates cell-cell interactions and regulates neurite outgrowth of sensory and motor neurons

The "ITGA8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ITGA8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets